Procept Biorobotics
PRCT
254 hedge funds and large institutions have $1.24B invested in Procept Biorobotics in 2026 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 107 increasing their positions, 66 reducing their positions, and 36 closing their positions.
208% more call options, than puts
Call options by funds: $17.1M | Put options by funds: $5.55M
62% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 66
8% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 36
1% less funds holding
Funds holding: 257 → 254 (-3)
2.58% less ownership
Funds ownership: 98.96% → 96.38% (-2.6%)
11% less capital invested
Capital invested by funds: $1.4B → $1.24B (-$158M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$27M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$21.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.2M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$18.1M |
| 5 |
BlackRock
New York
|
+$12.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$43M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$42M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28.2M |
| 4 |
M
Mirova
Paris,
France
|
-$17.8M |
| 5 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$17.2M |
PRCT Hedge Fund Activity: Q2 2026 in Review
254 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q2 2026, worth a combined $1.24B — down 11% from $1.4B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new PRCT positions and 36 closed out — a net gain of 3 holders — while 107 added to existing stakes and 66 trimmed.
The largest buyer was Federated Hermes, adding an estimated $27M. The largest seller was Mackenzie Financial, exiting entirely with an estimated $43M sold.
- 254 institutional investors held Procept Biorobotics (PRCT) as of Q2 2026, down from 257 in Q1 2026.
- Funds reported $1.24B of Procept Biorobotics stock for Q2 2026, down 11% quarter-over-quarter.
- 39 funds opened new Procept Biorobotics positions in Q2 2026 and 36 closed out, a net change of +3 holders.
- The largest Procept Biorobotics buyer in Q2 2026 was Federated Hermes, an estimated $27M added.
- The largest Procept Biorobotics seller in Q2 2026 was Mackenzie Financial, an estimated $43M sold.
Based on aggregated 13F filings for Q2 2026.